Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Market Cap	1.07T
Revenue (ttm)	1.59T
Net Income (ttm)	109.07B
Shares Out	13.18M
EPS (ttm)	8,234.46
PE Ratio	9.82
Forward PE	n/a
Dividend	997.73 (1.22%)
Ex-Dividend Date	Dec 27, 2024

Volume	23,792
Average Volume	24,256
Open	80,300
Previous Close	80,700
Day's Range	80,200 - 81,500
52-Week Range	77,400 - 124,000
Beta	0.80
RSI	48.42
Earnings Date	Mar 18, 2025

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair colo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 2,276
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 185750

Financial Performance

In 2024, KRX:185750's revenue was 1.59 trillion, a decrease of -4.97% compared to the previous year's 1.67 trillion. Earnings were 109.07 billion, a decrease of -48.68%.